http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1839651-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ac2c17e532220d91aca9a28ef60f178b |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-205 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2059 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1694 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1652 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2095 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-522 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-26 |
| filingDate | 2000-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c2017f88d103bb5074c2b0b4c50293d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e00a12345d46d4a374fcd1e6670ca451 |
| publicationDate | 2007-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-1839651-A1 |
| titleOfInvention | Method for producing a water-insoluble amorphous or partially amorphous controlled release matrix |
| abstract | The invention relates to a process for the preparation of drug forms or precursors thereof by means of extrusion, wherein the dosage form comprises a matrix containing the active substance substantially, which is formed by the extrusion in their essential properties, and a polysaccharide and / or a derivative thereof and / or a complex thereof and / or any mixture of the aforementioned substances with other substances and / or saccharides and / or derivatives thereof as an essential constituent of the matrix and at least one pharmaceutically active substance. The invention furthermore relates to a pharmaceutical form which comprises a matrix essentially containing the active substance content, which is formed by extrusion in its essential properties, and a polysaccharide and / or a derivative thereof and / or a complex thereof and / or any desired mixture of the abovementioned Substances comprising other substances and / or saccharides and / or derivatives thereof as an essential component of the matrix and at least one pharmaceutically active substance. Furthermore, the invention relates to the use of the drug form for the production of granules for tableting and capsule filling, for further processing by injection molding, as an excipient in direct tabletting and / or for the production of monoblock medicaments. |
| priorityDate | 1999-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 43.